在印度进行的干预性临床试验中的种族代表性
Jaishree Mendiratta1, Mounika Pillamarapu1, Indraneel Chakraborty1
1Institute of Bioinformatics and Applied Biotechnology, Biotech Park, Electronics City Phase 1, Bengaluru 560100, Karnataka, India.
The Lancet regional health. Southeast Asia
|August 24, 2023
概括
印度的临床试验往往无法代表该国的种族多样性. 大多数第三期试验只发生在一个地理区域,这可能导致对非代表性人口进行不道德的研究.
科学领域:
- 临床研究伦理学
- 卫生公平性健康公平性
- 药物开发 药物开发
背景情况:
- 全球强调增加临床试验参与者的多样性.
- 需要评估印度临床试验中的种族代表性.
研究的目的:
- 评估在印度注册的临床试验是否充分采样了该国的种族多样性.
- 确定干预性药物和生物研究的地理分布模式.
主要方法:
- 来自印度临床试验注册局的2期和3期干预药物/生物研究的分析.
- 在五年时间内,研究分布在六个定义的地理区域的检查.
主要成果:
- 仅在印度进行的第三阶段试验中有61.4%是在一个单一的地理区域进行的.
- 仅在印度进行的第三阶段试验中,只有6.8%的试验覆盖了所有六个区域.
- 多国III期试验显示地理分布更好,但仍然有限.
结论:
- 在大多数研究的试验中,印度的族群代表性不足.
- 对非代表性群体进行试验会引起有关安全性和有效性的伦理问题.
- 建议采取补救措施,以改善试验多样性和道德代表性.
更多相关视频
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Bias in Epidemiological Studies
352
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
352
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
147
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
147
Pharmacovigilance
889
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
889
Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K


